IL2 and COVID-19: Compared to nondiabetic COVID-19 patients, diabetic COVID-19 patients are characterized by a higher percentage of CD4+ T cell and a lower percentage of CD8+ T cells and higher serum levels of IL-6, IL-2, IL-10, and INFγ.